Cievert

Cievert is a UK-based health technology company that specializes in software solutions designed to improve patient outcomes and clinical efficiency, particularly in oncology and chronic disease management. Their flagship products, such as Casper and Penguin, facilitate patient-reported outcome measures (PROMs) and streamline clinical workflows for radiotherapy and other complex treatments. By digitizing patient pathways and automating follow-ups, Cievert helps healthcare providers identify issues earlier and manage large patient cohorts more effectively. The company's tools are widely used within the NHS to enhance the delivery of cancer care and long-term condition monitoring. In 2023, Cievert was acquired by The Doctors Laboratory (TDL) to integrate its digital health expertise with TDL's pathology services.